With near-certain market-implied odds exceeding 99 percent for a CDC Level 3 Travel Health Notice by year-end, trader consensus centers on sustained measles transmission across multiple U.S. states and emerging international risks. Official CDC surveillance through mid-May 2026 already documents over 1,800 confirmed cases, the majority outbreak-linked, alongside active Level 2 notices for Ebola and chikungunya that demonstrate the agency’s threshold for escalation when limited precautions exist. Historical patterns show Level 3 notices issued for high-risk outbreaks within similar timeframes, and ongoing model projections for respiratory and vector-borne diseases through summer and fall support continued monitoring by the CDC. Key upcoming data releases from surveillance networks could further solidify resolution criteria tied to geographic spread and case thresholds, though rapid containment or absence of novel high-risk events remains the primary low-probability scenario that could shift positioning before December 31.